Patent · US Active

Neuropilin antagonists

US7994286B2 · kind B2 · utility

14Cited by
17References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 22, 2008
Grant dateAug 9, 2011
Priority date—
Expiry dateNov 24, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel anti-NRP1 antibodies and variants thereof having unique structural and functional characteristics are disclosed. Also provided are uses of the antibodies in research, diagnostic and therapeutic applications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.